Compare BCYC & EAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCYC | EAD |
|---|---|---|
| Founded | 2009 | 2003 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 456.4M | 407.1M |
| IPO Year | 2019 | N/A |
| Metric | BCYC | EAD |
|---|---|---|
| Price | $5.68 | $6.80 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $19.10 | N/A |
| AVG Volume (30 Days) | ★ 442.2K | 140.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.91% |
| EPS Growth | ★ 42.91 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.03 | $5.89 |
| 52 Week High | $10.89 | $7.18 |
| Indicator | BCYC | EAD |
|---|---|---|
| Relative Strength Index (RSI) | 45.90 | 38.58 |
| Support Level | $5.03 | $6.75 |
| Resistance Level | $5.90 | $6.83 |
| Average True Range (ATR) | 0.30 | 0.04 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 72.83 | 22.22 |
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
Allspring Income Opportunities Fund is a diversified closed-end management investment company. Its products and services are mutual funds, closed-end funds, managed accounts services, and variable trust funds. The fund's objective is a high level of current income and capital appreciation. Its portfolio of investments is Commercial services, healthcare services, Food, Pharmaceuticals, Energy, Oil & gas, Pipelines, Diversified financial services, and Others.